The CDC licensed the test’s use by Quest Diagnostics and other select national reference laboratories to help with the response to the Zika virus outbreak.
Antibody tests are most useful two to 12 weeks following the onset of symptoms, while molecular testing is useful up to 14 days after symptom onset.
As of Sept. 14, more than 3,175 people in the U.S. had Zika, according to the CDC.
More articles on Zika:
Scientists able to detect traces of Zika from eye swabs
Florida Zika update: Miami Beach transmission zone expands, Wynwood makes progress in mosquito control
New science proves Zika causes microcephaly
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.